Expertise in
4
conditions

Lars Ny

Goeteborg, O, SE 
Expertise in
4
conditions
Goeteborg, O, SE 

Overview

Lars Ny practices practicing medicine in Goeteborg, Sweden.

Mr. Ny is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Melanoma, Uveal Melanoma, Metastatic Uveal Melanoma, and Melanoma of the Eye.

He is actively involved in clinical research, co-authoring 81 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Goeteborg, O, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

SCANDIUM II Trial - A Phase I Randomized Controlled Multicentre Trial of Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases
SCANDIUM II Trial - A Phase I Randomized Controlled Multicentre Trial of Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases
Enrollment Status: Completed
Publish Date: March 28, 2025
Intervention Type: Procedure, Drug
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 1
MEGALiT - a Multicenter, Basket and Umbrella Explorative Trial on the Efficacy and Safety of Molecular Profile Selected Commercially Available Targeted Anti-cancer Drugs in Patients With Advanced Cancers Progressive on Standard Therapy
MEGALiT - a Multicenter, Basket and Umbrella Explorative Trial on the Efficacy and Safety of Molecular Profile Selected Commercially Available Targeted Anti-cancer Drugs in Patients With Advanced Cancers Progressive on Standard Therapy
Enrollment Status: Unknown
Publish Date: August 22, 2024
Intervention Type: Drug
Study Phase: Phase 2
Surgery of Melanoma Metastases After Systemic Therapy - the SUMMIST Trial
Surgery of Melanoma Metastases After Systemic Therapy - the SUMMIST Trial
Enrollment Status: Withdrawn
Publish Date: January 26, 2024
Intervention Type: Drug, Procedure
Study Drug: Immunotherapy
Study Phase: Phase 2
View 2 Less Clinical Trials

81 Total Publications

Nodal localisation with magnetic seed in patients with stage III melanoma receiving neoadjuvant immune checkpoint inhibitors, a feasibility study.
Nodal localisation with magnetic seed in patients with stage III melanoma receiving neoadjuvant immune checkpoint inhibitors, a feasibility study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: April 20, 2026

Frequently Asked Questions about Lars Ny

Is Lars Ny a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Lars Ny is classified as an Distinguished expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Lars Ny participate in research or clinical trials?

Yes. Lars Ny has published 81 articles and abstracts on conditions like Melanoma. You can view a list of Lars Ny's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ny's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile